Corticosteroids after loss of ambulation in Duchenne muscular dystrophy: A dilemma for the ages-Reference-Cited by-同舟云学术

Corticosteroids after loss of ambulation in Duchenne muscular dystrophy: A dilemma for the ages

Published:2022-04-22 Issue:1 Volume:66 Page:1-2
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Paul Dustin¹,Kumar Ashutosh²^ORCID

Affiliation:

1. Department of Neurology University of Texas Rio Grande Valley Edinburg Texas USA

2. Department of Pediatrics and Neurology Penn State Health Children's Hospital and Penn State College of Medicine Hershey Pennsylvania USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27548

Reference14 articles.

1. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

2. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;Manzur AY;Cochrane Database Syst Rev,2008

3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management

4. Glucocorticoid Treatment for the Prevention of Scoliosis in Children with Duchenne Muscular Dystrophy: Long-Term Follow-up

5. Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non‐ambulatory males with Duchenne muscular dystrophy from MD STARnet;Butterfield R;Muscle Nerve,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02);Journal of Neurology;2023-12-06

2. What Is in the Myopathy Literature?;Journal of Clinical Neuromuscular Disease;2022-09